Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Net Income Margin

Intercept Pharmaceuticals Net Income Margin Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Net Income Margin from 2011 to 2020. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Intercept Pharmaceuticals Net Income Margin for the quarter ending June 06, 2020 was $-82m a -67.16% increase of 55m year over year
  • Intercept Pharmaceuticals Net Income Margin for the last 12 months ending June 06, 2020 was $-120m a -19.51% increase of 23m year over year
  • Intercept Pharmaceuticals Annual Net Income Margin for 2019 was $-137m a -25.74% increase of 35m from 2018
  • Intercept Pharmaceuticals Annual Net Income Margin for 2018 was $-172m a -60.00% increase of 103m from 2017
  • Intercept Pharmaceuticals Annual Net Income Margin for 2017 was $-275m a -501.26% increase of 1,379m from 2016
Other Margins & Efficiency Metrics:
  • Intercept Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $-152m a -36.16% increase of 55m year over year
  • Intercept Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -28.58 a -108.87% increase of 31.11 year over year
  • Intercept Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -175.89 a -126.61% increase of 222.69 year over year
View Chart On Koyfin

Quarterly ICPT Net Income Margin Data

06/2020$-82m
03/2020$-128m
12/2019$-137m
09/2019$-137m
06/2019$-108m
03/2019$-173m
12/2018$-165m
09/2018$-137m
06/2018$-173m
03/2018$-227m

Annual ICPT Net Income Margin Data

2019$-137m
2018$-172m
2017$-275m
2016$-1,655m
2015$-8,139m
2014$-16,259m
2013$-4,180m
2012$-1,784m
2011$-706m